ISS Stage III Plasma Cell Myeloma
4 clinical trials · Condition
◉ Watch ISS Stage III Plasma Cell Myeloma
| Record | Firm | Date |
|---|---|---|
| Combination Treatment Therapy Approaches for the Treatment of High-Risk Multiple Myeloma, REACH Trial (NCT05497804) | Mayo Clinic | 2022-09-22 |
| Pembrolizumab and Radiation Therapy in Patients With Relapsed or Refractory Multiple Myeloma (NCT03267888) | Emory University | 2018-05-29 |
| Personalized NK Cell Therapy in CBT (NCT02727803) | M.D. Anderson Cancer Center | 2016-05-19 |
| NK Cells in Cord Blood Transplantation (NCT01619761) | M.D. Anderson Cancer Center | 2013-05-03 |
Track ISS Stage III Plasma Cell Myeloma automatically
Every clearance here is in the API, with alerts when new ones post.